NASDAQ:XGN

Exagen Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy XGN

*Your capital is at risk

$4.54

-0.280 (-5.81%)

At Close: Jun 03, 2026

Exagen Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -63.16. In total, the insiders bought 2.36M and sold 1.32M XGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-63.16
● Buy	2.36M shares
● Sell	1.32M shares
80% Buy Activity Moderate Negative Correlation
Buy Signal Low Confidence Mar 12, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -63.16. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (80% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 10, 2025 Buy	Stock Option(right to buy) A-Award	Kim Paul Director	Director	9 000 Value: $66.2K
Mar 25, 2025 Sell	Common Stock S-Sale	Nmsic Co-investment Fund, L.p. 10 Percent Owner	10% Owner	350 000 Value: $1.16M
Mar 25, 2025 Sell	Common Stock S-Sale	Nmsic Co-investment Fund, L.p. 10 Percent Owner	10% Owner	350 000 Value: $1.16M
Feb 28, 2025 Buy	Common Stock A-Award	Aballi John President And CEO	CEO / President	8 621 Value: $21.3K
Feb 28, 2025 Buy	Common Stock A-Award	Aballi John President And CEO	CEO / President	8 621 Value: $21.3K
Feb 21, 2025 Buy	Common Stock A-Award	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	15 000 Value: $53.7K
Feb 21, 2025 Buy	Stock Option(right to buy) A-Award	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	10 000 Value: $35.8K
Feb 21, 2025 Buy	Common Stock A-Award	Aballi John President And CEO	CEO / President	112 500 Value: $402.8K
Feb 21, 2025 Buy	Stock Option(right to buy) A-Award	Aballi John President And CEO	CEO / President	75 000 Value: $268.5K
Feb 21, 2025 Buy	Stock Option(right to buy) A-Award	Aballi John President And CEO	CEO / President	75 000 Value: $268.5K
Feb 21, 2025 Buy	Common Stock A-Award	Aballi John President And CEO	CEO / President	112 500 Value: $402.8K
Feb 21, 2025 Buy	Stock Option(right to buy) A-Award	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	10 000 Value: $35.8K
Feb 21, 2025 Buy	Common Stock A-Award	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	15 000 Value: $53.7K
Nov 20, 2024 Sell	Common Stock S-Sale	Nmsic Co-investment Fund, L.p. 10 Percent Owner	10% Owner	200 000 Value: $660.0K
Nov 20, 2024 Sell	Common Stock S-Sale	Nmsic Co-investment Fund, L.p. 10 Percent Owner	10% Owner	200 000 Value: $660.0K
Nov 15, 2024 Buy	Common Stock P-Purchase	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	22 298 Value: $66.4K
Nov 15, 2024 Buy	Common Stock P-Purchase	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	22 298 Value: $66.4K
Nov 14, 2024 Buy	Common Stock J-Other	Aballi John President And CEO	CEO / President	0 Value: $0
Nov 14, 2024 Buy	Common Stock J-Other	Aballi John President And CEO	CEO / President	0 Value: $0
Nov 14, 2024 Buy	Common Stock P-Purchase	Aballi John President And CEO	CEO / President	24 305 Value: $68.3K
Nov 14, 2024 Buy	Common Stock P-Purchase	Aballi John President And CEO	CEO / President	24 305 Value: $68.3K
Sep 01, 2024 Buy	Common Stock	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	0 Value: $0
Sep 01, 2024 Buy	Common Stock A-Award	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	225 000 Value: $1.02M
Sep 01, 2024 Buy	Common Stock A-Award	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	225 000 Value: $1.02M
Sep 01, 2024 Buy	Common Stock	Black Jeffrey G. Chief Financial Officer	C-Suite Officer	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT EXAGEN INC.

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables diff...

Read Full Profile Here